SISB INVESTMENT ADVISERS (UK) LTD

Institutional investor · Portfolio as of Q2 2025

SEC EDGAR SourceSEC Filings

Top Holdings10 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

COUPANG INC

309.5M$9.3B73.5%$48.75-36.80%
18 qtrssince 2021-Q1
Decreased
0

GRAB HOLDINGS LTD - CL A

401.8M$2B16.0%$7.08-30.55%
15 qtrssince 2021-Q4
Unchanged
0

ROIVANT SCIENCES LTD

60M$675.7M5.4%$10.64+7.05%
15 qtrssince 2021-Q4
Decreased
0

COMPASS INC

48.1M$301.9M2.4%$13.50-52.52%
17 qtrssince 2021-Q2
Unchanged
0

AURORA INNOVATION INC

19.8M$103.8M0.8%$11.41-54.69%
15 qtrssince 2021-Q4
Decreased
0

RELAY THERAPEUTICS INC

27.9M$96.6M0.8%$39.98-91.75%
20 qtrssince 2020-Q3
Unchanged
0

VIR BIOTECHNOLOGY INC

16.7M$84.1M0.7%$12.12-57.34%
23 qtrssince 2019-Q4
Unchanged
0
YMMYMM
ADR

FULL TRUCK ALLIANCE CO LTD

3.2M$37.8M0.3%$10.02+17.91%
12 qtrssince 2022-Q3
Decreased
0

ENERGY VAULT HOLDINGS INC

18.5M$13.3M0.1%$9.89-93.43%
13 qtrssince 2022-Q2
Unchanged
0

GINKGO BIOWORKS HOLDINGS INC

610,729$6.9M0.1%$67.60-86.01%
11 qtrssince 2022-Q4
Unchanged
0
$12.6B
AUM
10
Positions
Q2 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
-10%Q1'24$10.1B+7%Q2'24$10.8B+12%Q3'24$12.1B-6%Q4'24$11.4B-4%Q1'25$11B+15%Q2'25$12.6B
Activity profile
$ moved · Q2'25
New0%Increased0%Decreased100%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.7 years
<1Q0%1-4Q0%1-2Y0%2Y+100%

SB INVESTMENT ADVISERS (UK) LTD manages $12.6B across 10 positions as of Q2 2025. Top holdings: CPNG (73.5%), GRAB (16.0%), ROIV (5.4%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.

Q2 2025 Summary

Trimmed 4. No standout high-conviction moves this quarter. Portfolio: $12.6B across 10 positions.

Top holdings by portfolio weight

Total AUM$13B
CPNG73.52%
GRAB16.02%
ROIV5.36%
COMP2.39%
AUR0.82%
RLAY0.77%
VIR0.67%
YMM0.30%
NRGV0.11%
DNA0.05%

Portfolio allocation by GICS sector

Sectors5
Consumer Cyclical73.52%
Technology17.14%
Healthcare6.84%
Real Estate2.39%
Utilities0.11%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Consumer Cyclical, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction37
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used